Clinical Trials on Plasmodium Vivax Malaria Without Complication in Hong Kong

Total 5 results

Novartis Pharmaceuticals
MMV, EDCTP, WANECAM

Recruiting

Efficacy, Safety and Tolerability of KLU156 in Adults and Children ≥ 5 kg Body Weight With Uncomplicated P. Falciparum Malaria (KALUMA)

Uncomplicated Plasmodium Falciparum Malaria

Congo, The Democratic Republic of the
Ministry of Public Health, Democratic Republic...
Centers for Disease Control and Prevention; Global Fund

Active, not recruiting

Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the Congo (TES2022)

Uncomplicated Plasmodium Falciparum Malaria

Congo, The Democratic Republic of the
HuLow
University of Turin, Italy; Purdue University; Università degli Studi di Sassari and other collaborators

Completed

Effect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria (MIM)

Plasmodium Falciparum Malaria

Vietnam
Novartis Pharmaceuticals
European and Developing Countries Clinical Trials Partnership (EDCTP); Medicines... and other collaborators

Active, not recruiting

Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria (CALINA)

Plasmodium Falciparum Malaria

Burkina Faso, Congo, The Democratic Republic of the
Dr. Prayuth Sudathip
Medicines for Malaria Venture

Completed

Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure After G6PD Testing in Thailand (ARCTIC)

Malaria, Vivax | G6PD Deficiency

Thailand

Clinical Trials on Plasmodium Vivax Malaria Without Complication in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations